Free Shipping & Returns in 24h on more than 300.000 products
Accumulate credit with every order
100% secure payment
More than 6 million products shipped
Hola,
Menú principal
Nombre categoria
Marcas Destacadas
BioTechUSA Brutal Knee Brace 2m
Roll the mouse over to enlarge the image
imagen producto

BioTechUSA Brutal Knee Brace 2m

Recommended
22,84 € 24,73 €
+12,99 € shipping See details
  • To protect you from possible injury .

  • Created with high resistance materials.

  • Contains 2 tapes.

  • 2 meters.

fast shipping
more than 300.000 + info
100% Secure Payment
on all your purchases
22,84 € 24.73€
+12,99 € shipping See details
Entrega: Monday, 06 de May
Sold and shipped by Bulevip
Do you have a Bulevip balance? See more Balance applicable to this product See details
Share:

Do you have any questions?

Ask a question to the community if you have any questions about this product.

Product information BioTechUSA Brutal Knee Brace 2m

BIOTECH INFORMATION USA BRUTAL KNEE SUPPORT

Brutal knee wraps from BioTech USA are good for protecting your knees from possible injuries .

Made of resistant materials to guarantee maximum protection and quality.

SIZE

Only.

COLOR

Red and black, American style.

CONTENT

2 Tapes.

SIZE

2 meters.

RECOMMENDED COMBINATIONS

  • BiotechUSA has created a range of products called endurance that is aimed at endurance athletes, such as its Energy Gel PRO energy gel.

  • To completely satisfy the needs of all athletes, they also have sports accessories, such as gloves , grips or belts.

  • BioTechUSA Iso Whey Zero 2270 gr : it is a high purity protein, made with carefully selected raw materials. Biotech USA Iso Whey Zero contains more than 88% pure protein, is low in fat and carbohydrates, and is gluten and lactose free.

Questions and answers from customers

No questions for this product yet.

Do you want to ask the community a question about this product?

Customer feedback

4.8
4.8 5-star
5 customer reviews
1 stars
2 stars
3 stars
4 stars
5 stars
With certificate of trust Opinions subject to scrutiny